Clinical Significance of Pharmacogenomic Studies in Tardive Dyskinesia Associated With Patients With Psychiatric Disorders

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s52806
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Persistent Akathisia Associated With Early Tardive Dyskinesia.

Postgraduate Medical Journal
Medicine
1984English

Effect of Quetiapine in Young Schizophrenic Patients With Tardive Dyskinesia

Annals of General Psychiatry
PsychiatryMental Health
2010English

Tardive Dyskinesia Treated With Clonidine.

Kurume Medical Journal
Medicine
1980English

Tardive Dyskinesia

2019English

Treatment of Tardive Dyskinesia With Choline and Tetrabenazine.

Postgraduate Medical Journal
Medicine
1980English

Tardive Dyskinesia.

BMJ
1979English

Tardive Dyskinesia and Other Extrapyramidal Symptoms Associated With Aripiprazole: A Case Series

Journal of Evolution of Medical and Dental Sciences
2016English

Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients With Tardive Dyskinesia Is Associated With Abnormal Involuntary Movement

Scientific Reports
Multidisciplinary
2018English

Clonazepam in Tardive Dyskinesia

Irish Journal of Psychological Medicine
PsychiatryMental HealthPhilosophy of ScienceApplied PsychologyHistory
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy